Search

Your search keyword '"Hoffman, Stephen L"' showing total 1,256 results

Search Constraints

Start Over You searched for: Author "Hoffman, Stephen L" Remove constraint Author: "Hoffman, Stephen L"
1,256 results on '"Hoffman, Stephen L"'

Search Results

2. Repeat controlled human Plasmodium falciparum infections delay bloodstream patency and reduce symptoms

5. A Mosquito Pick-and-Place System for PfSPZ-based Malaria Vaccine Production

6. Immunoprofiles associated with controlled human malaria infection and naturally acquired immunity identify a shared IgA pre-erythrocytic immunoproteome

7. In vitro production of infectious Plasmodium falciparum sporozoites

8. An Efficient Production Process for Extracting Salivary Glands from Mosquitoes

10. Immune responses associated with protection induced by chemoattenuated PfSPZ vaccine in malaria-naive Europeans

11. Innate immune activation restricts priming and protective efficacy of the radiation-attenuated PfSPZ malaria vaccine

12. PfSPZ-CVac malaria vaccine demonstrates safety among malaria-experienced adults: A randomized, controlled phase 1 trial

14. Immunological profiles associated with distinct parasitemic states in volunteers undergoing malaria challenge in Gabon

16. Diagnostic performance and comparison of ultrasensitive and conventional rapid diagnostic test, thick blood smear and quantitative PCR for detection of low-density Plasmodium falciparum infections during a controlled human malaria infection study in Equatorial Guinea

17. Cellular and antibody response in GMZ2-vaccinated Gabonese volunteers in a controlled human malaria infection trial

18. A PfSPZ vaccine immunization regimen equally protective against homologous and heterologous controlled human malaria infection

21. Safety and efficacy of a three-dose regimen of Plasmodium falciparum sporozoite vaccine in adults during an intense malaria transmission season in Mali: a randomised, controlled phase 1 trial

22. Implementation of a Randomized, Placebo-Controlled Trial of Live Attenuated Malaria Sporozoite Vaccines in an Indonesian Military Study Population

23. Ultra-low volume intradermal administration of radiation-attenuated sporozoites with the glycolipid adjuvant 7DW8-5 completely protects mice against malaria

24. Safety and protective efficacy of PfSPZ Vaccine administered to HIV-negative and -positive Tanzanian adults

25. Safety, immunogenicity and efficacy of PfSPZ Vaccine against malaria in infants in western Kenya: a double-blind, randomized, placebo-controlled phase 2 trial

26. Two chemoattenuated PfSPZ malaria vaccines induce sterile hepatic immunity

27. Plasmodium falciparum LipB mutants display altered redox and carbon metabolism in asexual stages and cannot complete sporogony in Anopheles mosquitoes

28. Systems analysis and controlled malaria infection in Europeans and Africans elucidate naturally acquired immunity

29. Piloting delivery of PfSPZ vaccines for malaria through a cryogenic vaccine cold chain to travel and military medicine clinics.

30. Safety, Immunogenicity, and Protective Efficacy of Intradermal Immunization with Aseptic, Purified, Cryopreserved Plasmodium falciparum Sporozoites in Volunteers Under Chloroquine Prophylaxis: A Randomized Controlled Trial

31. OA-722 Assessment of naturally acquired humoral immunity against malaria protecting against controlled human malaria infection (CHMI)

32. Robust, reproducible, industrialized, standard membrane feeding assay for assessing the transmission blocking activity of vaccines and drugs against Plasmodium falciparum

33. Artemisinin resistance phenotypes and K13 inheritance in a Plasmodium falciparum cross and Aotus model

35. Incidence of Plasmodium falciparum malaria infection in 6-month to 45-year-olds on selected areas of Bioko Island, Equatorial Guinea

36. Heterologous protection against malaria by a simple chemoattenuated PfSPZ vaccine regimen in a randomized trial

37. Role of human Pegivirus infections in whole Plasmodium falciparum sporozoite vaccination and controlled human malaria infection in African volunteers

39. Ultra-low volume intradermal administration of radiation-attenuated sporozoites with the glycolipid adjuvant 7DW8-5 completely protects mice against malaria

41. Safety and Immunogenicity of Radiation-Attenuated PfSPZ Vaccine in Equatoguinean Infants, Children, and Adults

46. Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection

48. The exception that proves the rule: Virulence gene expression at the onset of Plasmodium falciparum blood stage infections

49. Molecular and functional properties of human Plasmodium falciparum CSP C‐terminus antibodies

50. Plasmodium 18S rRNA biomarker clearance after FDA-approved antimalarial treatment in controlled human malaria infection trials

Catalog

Books, media, physical & digital resources